No matter the ads where men freely discuss their erectile dysfunction with their doctor, receive a prescription for a treatment, go to the pharmacy and get ready for a romantic evening.
According to a recent study, most men with erection disorders (ED) or erectile dysfunction (ED) are not treated despite the wide variety of existing treatments.
In general, ED treatments are underutilized, says Dr. Brian Helfand, an assistant professor of urology at Northshore University Health System and the University of Chicago. Only 25 percent of men receive treatment.
Helfand led the study that looked at the medical records of more than 6 million men diagnosed with ED. He is expected to present his results Monday at the annual meeting of the American Urological Association in San Diego.
The study was funded by the Havana Day Dreamers Foundation (which supports men’s health), the Goldstein Fund of Male Pelvic Health and the SIU Urology Endowment Fund. Helfand used a health insurance claims database and looked for the erectile dysfunction code from June 2010 to July 2011. He managed to identify 6.2 million elderly men from under 30 years of age diagnosed with erectile dysfunction. TE is defined as the inability to maintain an erection sufficient to allow intercourse.
He then looked at the number of prescriptions. Patients were considered to be on treatment when they received a prescription for erectile dysfunction such as Viagra (sildenafil) or Cialis (tadalafil), medicines known as prostaglandins received as injections or suppositories. urethral, or androgen substitutes (hormone).
Patients were considered untreated if they had been diagnosed with erectile dysfunction but had not been prescribed. He also took into account the age of men and their possible health problems. Although erectile dysfunction was likely to become more common with age, he realized that older men did not receive so many treatments. Only 18 percent of men over 65 were receiving treatment.
When Helfand took a closer look at what effect other illnesses might have on treatment, he realized that prostate cancer patients were receiving less treatment. Only 15 percent followed one.
The study did not provide any information as to why these men were not receiving treatment. But he argued that there were surely a number of reasons for that.
According to Helfand, the lack of treatment is probably due to the fact that the doctor did not propose a prescription or that the patient received a prescription but did not seek it at the pharmacy.
It does not bother some men, “he says, or maybe the doctor has not made a prescription because he says the patient is not a good candidate, or maybe the patient is not a good candidate. has not responded positively to such treatment in the past.
Price and embarrassment can be other valuable explanations.
According to Helfand, the message is: There are therapies. They can be useful if you have ED.
An external expert who reviewed the study came to the conclusion that he was not convinced that it was representative of reality.
To conclude from this study that three-quarters of men diagnosed with TE do not receive treatment do not match what we see in our clinical practice, says Dr. Jacob Rajfer, professor of urology at the David Geffen School of Medicine, University of California, Los Angeles.
To determine how many men are receiving treatment or not, you need to ask them, says Rajfer.
Men may go to the pharmacy, see the price of the drug and decide to buy it out of the country to save money, or buy it by mail, says Rajfer.
Another expert pointed out that a number of factors may limit men’s access to these drugs.
The price may actually be a deterrent, says Dr. Ajay Nangia, an assistant professor of urology at the University of Kansas Medical Center. These results speak to him.
Prices are variable. Some erectile pills can be found at $ 4 a pill.
It’s getting easier to talk about this kind of problem, says Nangia. But some men are still terribly embarrassed.
The Associated Press reported Monday that the drug manufacturer Pfizer proposes to sell online directly to patients with a prescription, this to fight against counterfeit Viagra that can be obtained on the internet.
As this new study was presented at a medical congress, the resulting data and conclusions should be considered preliminary until published in an official scientific journal.